1,014 filings
Page 2 of 51
10-Q
2023 Q3
FGEN
FibroGen Inc
Quarterly report
6 Nov 23
4:11pm
8-K
FGEN
FibroGen Inc
6 Nov 23
FibroGen Reports Third Quarter 2023 Financial Results
4:05pm
4
FGEN
FibroGen Inc
3 Nov 23
FIBROGEN / Thane Wettig ownership change
4:20pm
8-K
FGEN
FibroGen Inc
27 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
FGEN
FibroGen Inc
5 Oct 23
Departure of Directors or Certain Officers
7:41pm
4
FGEN
FibroGen Inc
25 Sep 23
FIBROGEN / Thane Wettig ownership change
7:37pm
4
Juan Graham
8 Sep 23
FIBROGEN / Juan Graham ownership change
5:03pm
4
Thane Wettig
8 Sep 23
FIBROGEN / Thane Wettig ownership change
5:00pm
4
Mark Eisner
8 Sep 23
FIBROGEN / Mark Eisner ownership change
4:59pm
4
Chung Christine
8 Sep 23
FIBROGEN / Christine Chung ownership change
4:58pm
4
Mark Eisner
6 Sep 23
FIBROGEN / Mark Eisner ownership change
8:55pm
4
Henderson Jeffrey William
6 Sep 23
FIBROGEN / Jeffrey William Henderson ownership change
8:54pm
8-K
FGEN
FibroGen Inc
6 Sep 23
Departure of Directors or Certain Officers
8:55am
4
Juan Graham
1 Sep 23
FIBROGEN / Juan Graham ownership change
7:38pm
4
Chung Christine
1 Sep 23
FIBROGEN / Christine Chung ownership change
7:37pm
144
FGEN
FibroGen Inc
1 Sep 23
Notice of proposed sale of securities
5:31pm
8-K
FGEN
FibroGen Inc
29 Aug 23
FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular Dystrophy
5:14pm
4
Schoeneck James A
14 Aug 23
FIBROGEN / James A Schoeneck ownership change
5:00pm
4
Thane Wettig
9 Aug 23
FIBROGEN / Thane Wettig ownership change
5:28pm
4
FGEN
FibroGen Inc
8 Aug 23
FIBROGEN / Jeffrey William Henderson ownership change
7:10pm